CA2350388A1 - Hydrolases humaines - Google Patents

Hydrolases humaines Download PDF

Info

Publication number
CA2350388A1
CA2350388A1 CA002350388A CA2350388A CA2350388A1 CA 2350388 A1 CA2350388 A1 CA 2350388A1 CA 002350388 A CA002350388 A CA 002350388A CA 2350388 A CA2350388 A CA 2350388A CA 2350388 A1 CA2350388 A1 CA 2350388A1
Authority
CA
Canada
Prior art keywords
leu
gly
ser
ala
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002350388A
Other languages
English (en)
Inventor
Y. Tom Tang
Jennifer L. Hillman
Henry Yue
Preeti Lal
Olga Bandman
Neil C. Corley
Karl J. Guegler
Mariah R. Baughn
Dyung Aina M. Lu
Yalda Azimzai
Junming Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2350388A1 publication Critical patent/CA2350388A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des hydrolases humaines (HYDRL), ainsi que des polynucléotides identifiant et codant pour HYDRL. Elle se rapporte également à des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes, et propose des méthodes de diagnostique, de traitement ou de prévention de troubles associés à l'expression de HYDRL.
CA002350388A 1998-11-12 1999-11-12 Hydrolases humaines Abandoned CA2350388A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17225698P 1998-11-12 1998-11-12
US60/172,256 1998-11-12
US13551999P 1999-05-21 1999-05-21
US60/135,519 1999-05-21
PCT/US1999/027009 WO2000028045A2 (fr) 1998-11-12 1999-11-12 Hydrolases humaines

Publications (1)

Publication Number Publication Date
CA2350388A1 true CA2350388A1 (fr) 2000-05-18

Family

ID=26833410

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002350388A Abandoned CA2350388A1 (fr) 1998-11-12 1999-11-12 Hydrolases humaines

Country Status (5)

Country Link
EP (1) EP1131443A2 (fr)
JP (1) JP2003528567A (fr)
AU (1) AU1914400A (fr)
CA (1) CA2350388A1 (fr)
WO (1) WO2000028045A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002535001A (ja) * 1999-01-26 2002-10-22 ユニバーシテイ・カレツジ・ロンドン スクリーニング方法
AU3097301A (en) * 2000-01-19 2001-07-31 University Of Virginia Patent Foundation Sperm specific lysozyme-like proteins
US7125550B2 (en) 2000-01-19 2006-10-24 University Of Virginia Patent Foundation Human sperm specific lysozyme-like proteins
WO2001059132A1 (fr) * 2000-02-11 2001-08-16 Lexicon Genetics Incorporated Nouvelles lysozymes humaines et polynucleotides codant pour elles
US6500657B1 (en) * 2000-03-31 2002-12-31 Millennium Pharmaceuticals, Inc. 33167, a novel human hydrolase and uses therefor
EP1297155A2 (fr) * 2000-06-29 2003-04-02 Millennium Pharmaceuticals, Inc. 25869, nouvelle carboxylesterase humaine et ses utilisations
AU2001277109A1 (en) * 2000-07-21 2002-02-05 Millennium Pharmaceuticals, Inc. 56939, a human acyl-coa thioesterase family member and uses thereof
CA2423953A1 (fr) * 2000-09-29 2002-04-04 Incyte Genomics, Inc. Hydrolases
AR088699A1 (es) * 2011-11-09 2014-06-25 Sanofi Sa Diacilglicerol lipasa y usos de la misma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537547B1 (en) * 1996-06-07 2003-03-25 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Polypeptides having L-asparaginase activity
US5958750A (en) * 1996-07-03 1999-09-28 Inctye Pharmaceuticals, Inc. Human hyaluronidase

Also Published As

Publication number Publication date
WO2000028045A2 (fr) 2000-05-18
EP1131443A2 (fr) 2001-09-12
JP2003528567A (ja) 2003-09-30
WO2000028045A3 (fr) 2000-10-26
AU1914400A (en) 2000-05-29

Similar Documents

Publication Publication Date Title
CA2357146A1 (fr) Phosphodiesterase-nucleotide cyclique humaine
CA2380317A1 (fr) Synthetases humaines
US6660485B2 (en) Antibodies to human goose-type lysozyme
CA2383907A1 (fr) Enzymes hydrolytiques humains
EP1144625A2 (fr) Proteines liant des acides nucleiques
CA2350388A1 (fr) Hydrolases humaines
CA2409781A1 (fr) Phosphodiesterases
CA2448148A1 (fr) Proteines associees aux carbohydrates
WO2000028034A2 (fr) Regulateurs de signaux de la cytokine
CA2348833A1 (fr) Phospholipases humaines
WO2000011171A2 (fr) Proteines humaines associees a l'arn
CA2369342A1 (fr) Enzymes modifiant les hydrates de carbone
US5989822A (en) ATP synthase subunit homolog
CA2349586A1 (fr) Coenzyme a utilisant des enzymes
CA2336262A1 (fr) Tri de nexines
WO2000049043A2 (fr) Proteines humaines associees aux lipides
US20040054138A1 (en) Phosphodiesterases
CA2329688A1 (fr) Proteines de regulation du cycle cellulaire
CA2390689A1 (fr) Lyases humaines et proteines associees
WO2000024779A1 (fr) Proteine statherine riche en lysine
EP1481081A2 (fr) Molecules associees a des lipides
CA2335644A1 (fr) Effecteurs de phosphorylation

Legal Events

Date Code Title Description
FZDE Dead